The BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to making sure that the best new treatments reach patients in the clinic as quickly as possible. The journal reflects these aims. It was founded more than fifty ...
British Journal of Cancer (2009) 100, 50 – 55. doi:10.1038/sj.bjc.6604829 www.bjcancer.com Published online 16 December 2008 & 2009 Cancer Research UK Keywords: carboplatin; chemotherapy; irinotecan; unknown primary Carcinoma of unknown primary site (CUP) represents a group of heterogeneous ...
From course 2 onwards, British Journal of Cancer (2012) 106(1), 70 – 76 & 2012 Cancer Research UK treatment was allowed to be postponed for up to 2 weeks, but only two such postponements were allowed. The median duration of treatment was five cycles. Overall, 18 patients (40.0%) ...
The Drug Development Unit of the Royal Marsden NHS Foundation Trust and The Institute of Cancer Research are supported in part by a program grant from Cancer Research UK. Support was also provided by the Experimental Cancer Medicine Centre (to The Institute of Cancer Research)....
Present address: Cancer Research Unit, Medical School, University of Newcastle upon Tyne, NE2 4HH, Newcastle, UK Authors and Affiliations Cancer Research Unit, Medical School, University of Newcastle upon Tyne, NE2 4HH, Newcastle, UK Saad Ghazal-Aswad & A. Hilary Calvert Rights and permissions...
Cancer Treat. Rep. 69:43 (1985). A.H. Calvert, et al. Cancer Chemother. Pharmacol. 9:140 (1982). 产品留言 标题 联系人 联系电话 内容 验证码 点击换一张 注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!2.如有必要,请您留下您的详细联系方式! 相关产品 ...
Eighty-five patients were recruited from 17 UK centres. The median OS was 41.7 months (95% confidence interval [CI] 19.6 to not reached) in the OxCapRT arm and was not reached in the CarPacRT arm (multivariable hazard ratio [HR] = 0.48, 95% CIs: 0.24–0.95, P = 0.035). The median...
Research in context Evidence before this study Pediatric high-grade gliomas (HGG) are highly malignant brain tumors with a devastating prognosis, contributing to the most cancer related mortalities in children. Expression of FANCD2, a member of the Fanconi anemia group genes, known to be involved ...
doi:10.1038/bjc.2011.566 www.bjcancer.com Published online 10 January 2012 & 2012 Cancer Research UK Keywords: ovarian cancer; p57Kip2; epigenetically silenced; carboplatin resistance; seliciclib p57Kip2 is a member of the CIP/KIP family of cyclin-dependent kinase inhibitors (CDKI). Each member...
Division of Clinical Studies, Institute of Cancer Research, London, UK Johann de Bono Royal Marsden, Hospital, London, UK Johann de Bono Contributions HAB, JB, TA, GMC, MPL, and JB were involved in data acquisition, analysis, and interpretation; JFP and AK conceptualised and designed the stu...